Why diabetes matters in dementia studies: Failure to account for diabetes status masks regional mitochondrial DNA copy number changes in human hippocampus, amygdala, and cerebellum in Alzheimer's disease
Why diabetes matters in dementia studies: Das Nichtberücksichtigen des Diabetesstatus maskiert regionale Veränderungen der mtDNA-Kopienzahl im menschlichen Hippocampus, in der Amygdala und im Kleinhirn bei Alzheimer-Krankheit
Alzheimer's & Dementia · 2026-10 · 22 (10)
DOI: 10.1002/alz.71870 ↗Auf einen Blick
Bei Alzheimer-Krankheit war die mtDNA-Kopienzahl in mehreren Hirnregionen niedriger, vor allem ohne Diabetes. Diabetes war mit höheren mtDNA-Kopienzahlen verbunden und kann die Unterschiede maskieren.
Fragestellung
Ob Alzheimer-Krankheit mit einer verringerten mtDNA-Kopienzahl in anfälligen Hirnregionen verbunden ist und ob Diabetes diese Veränderungen beeinflusst.
Methode
Absolute quantitative PCR an post-mortem Hippocampus, Amygdala und Kleinhirn von kognitiven Kontrollen, Alzheimer-Gruppen und Diabetes-Gruppen (N = 66–77).
Ergebnisse
Die mtDNA-Kopienzahl war regionsabhängig am höchsten in der Amygdala, dazwischen im Hippocampus und am niedrigsten im Kleinhirn (503, 421 und 160 Kopien/Zelle; p < 0,0001). Diabetes war mit höheren Werten verbunden; ohne Diabetes zeigte sich bei Alzheimer ein Rückgang um 19 %–30 %.
Schlussfolgerung der Autor:innen
Alzheimer-Krankheit ist mit einem multiregionalen Verlust der mtDNA-Kopienzahl verbunden, am klarsten bei Spender:innen ohne Diabetes. Diabetes erhöht die mtDNA-Kopienzahl und kann Alzheimer-assoziierte mitochondriale Veränderungen maskieren.
Kernaussagen
- MtDNA-Kopienzahl: Amygdala > Hippocampus > Kleinhirn
- Diabetes war mit höheren mtDNA-Kopienzahlen verbunden
- Ohne Diabetes zeigte sich bei Alzheimer ein Rückgang der mtDNA-Kopienzahl
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 20.10.2026. Verfasst von Aakruti Kaikini und 7 weiteren Autor:innen. Beteiligte Einrichtung: King's College London, Diabetes and Obesity, School of Cardiovascular Medicine and Metabolic Sciences, Faculty of Life Sciences and Medicine, London,…. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Alzheimer Disease, Cerebellum, Hippocampus. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, European Union, Alzheimer's Research UK (Interdisciplinary Research.
Themen: Demenz, Diabetes mellitus
Abstract (Originalsprache)
INTRODUCTION Diabetes is a major risk factor for Alzheimer's disease (AD), and both diseases involve mitochondrial dysfunction. Changes in mitochondrial DNA (mtDNA) can influence energy metabolism, cellular signaling, and epigenetic programming, thereby affecting cellular health. We hypothesized that AD is associated with reduced mtDNA copy number (mtDNA‐CN) in vulnerable brain regions, and that diabetes modifies these changes. METHODS MtDNA‐CN was quantified by absolute quantitative polymerase chain reaction (qPCR) in post‐mortem hippocampus, amygdala, and cerebellum from cognitive controls (CCs), AD, and diabetes groups (CC+D, AD+D; N = 66–77). RESULTS MtDNA‐CN differed by region, being highest in amygdala, intermediate in hippocampus, and lowest in cerebellum (503, 421, and 160 copies/cell; p < 0.0001). Pooled analyses showed modestly lower mtDNA‐CN in AD. However, inclusion of diabetes appeared to mask differences. Donors with diabetes (CC+D and AD+D combined) had higher mtDNA‐CN than non‐diabetic (CC and AD combined) in hippocampus (+37.5%; p = 0.0012), amygdala (+30.6%; p = 0.0057), and cerebellum (+48.5%; p = 0.0002). This diabetes‐associated increase was also present within AD, where AD+D had higher mtDNA‐CN than AD in all regions. Removal of diabetic donors showed that AD was associated with a 19%–30% lower mtDNA‐CN, reaching significance in the amygdala and cerebellum after correction for multiple testing. DISCUSSION We show that AD is associated with multiregional mtDNA‐CN loss most clearly in donors without diabetes, whereas diabetes is associated with higher mtDNA‐CN and can mask AD‐related mitochondrial changes. The functional significance of higher mtDNA‐CN in the diabetic brain remains unclear, but evidence that diabetes acts as an effect modifier has important implications for dementia studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- King's College London, Diabetes and Obesity, School of Cardiovascular Medicine and Metabolic Sciences, Faculty of Life Sciences and Medicine, London, England.
- Dept of Clinical and Biomedical Sciences, University of Exeter, University of Exeter Medical School, London, England.
- University of Kansas Alzheimer's Disease Research Center, University of Kansas School of Medicine, Fairway, Kansas, USA.
- Neurodegenerative Diseases Brain Bank, Department of Clinical and Basic Neuroscience, Institute of Psychiatry, Psychology &Neuroscience, King's College London, London, England.
- Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, King's College London, London, England.
ORCID-Profile: Afshan N Malik
Förderung
- NIA NIH HHS
- European Union
- Alzheimer's Research UK (Interdisciplinary Research
- European Commission
- National Institute on Aging
Zitieren
APA
Kaikini, A., Shi, A., Francis, P., Swerdlow, R., Troakes, C., Kennedy, J., Hodgkinson, A., & Malik, A. N. (2026). Why diabetes matters in dementia studies: Failure to account for diabetes status masks regional mitochondrial DNA copy number changes in human hippocampus, amygdala, and cerebellum in Alzheimer's disease. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71870
Vancouver
Kaikini A, Shi A, Francis P, Swerdlow R, Troakes C, Kennedy J, et al. Why diabetes matters in dementia studies: Failure to account for diabetes status masks regional mitochondrial DNA copy number changes in human hippocampus, amygdala, and cerebellum in Alzheimer's disease. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71870
BibTeX
@article{Kaikini2026,
author = {Kaikini, Aakruti and Shi, Anqi and Francis, Paul and Swerdlow, Russell and Troakes, Claire and Kennedy, Jaimee and Hodgkinson, Alan and Malik, Afshan N},
title = {Why diabetes matters in dementia studies: Failure to account for diabetes status masks regional mitochondrial DNA copy number changes in human hippocampus, amygdala, and cerebellum in Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {10},
doi = {10.1002/alz.71870}
}
EUVIMED